Zepp Health Corporation (ZEPP) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Apr 24, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ZEPP SEC filings page.
Zepp Health Corporation (ZEPP) reported $258.9M in revenue for fiscal year 2025, up 41.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The FY2025 rebound improved margins, but operations still consumed cash and left the balance sheet increasingly dependent on short-term funding.
Revenue rose41.8% from FY2024 while gross margin held at38.3% , yet operating losses remained; the rebound did not restore operating leverage. Operating cash flow of-$25.7M alongside free cash flow of-$26.2M , despite capital spending being only a small reported outlay, indicates the cash shortfall came mainly from ongoing operations rather than reinvestment.
The current ratio fell from 1.3x in FY2024 to 1.0x in FY2025, leaving less short-term cushion. Current liabilities reached
Gross margin rose from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Zepp Health Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Zepp Health Corporation has an operating margin of -11.3%, meaning the company loses $11 on every $100 of revenue. This results in a profitability score of 23/100. This is up from -25.9% the prior year.
Zepp Health Corporation's revenue surged 41.8% year-over-year to $258.9M, reflecting rapid business expansion. This strong growth earns a score of 6/100.
Zepp Health Corporation carries a low D/E ratio of 0.28, meaning only $0.28 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 71/100, indicating a strong balance sheet with room for future borrowing.
Zepp Health Corporation's current ratio of 1.02 is below the typical benchmark, resulting in a score of 19/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Zepp Health Corporation's operations used $25.7M of cash, and capex of $516K added to the outflow, for a free cash flow shortfall of $26.2M. This results in a cash flow score of 14/100.
Zepp Health Corporation posts a -18.7% return on equity (ROE), meaning it loses $19 for every $100 of shareholders' equity. This results in a returns score of 25/100. This is up from -30.1% the prior year.
Zepp Health Corporation scores 0.37, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Zepp Health Corporation passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Zepp Health Corporation reported a net loss of $40.1M while operations used $25.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Zepp Health Corporation reported an operating loss of $29.2M against $5.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Zepp Health Corporation held $57.0M in cash against $59.5M in long-term debt as of Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
ZEPP Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
ZEPP Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q4'2420-F | Q4'2310-K | Q4'2210-K | Q4'2110-K | Q4'2010-K | Q4'1910-K | Q4'1810-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $564.8M+6.9% | $528.6M-16.8% | $635.5M-16.8% | $763.7M-20.0% | $955.0M+5.5% | $904.8M+21.7% | $743.3M+56.8% | $473.9M+110.4% |
| Current Assets | $293.5M+16.7% | $251.6M-20.6% | $316.7M-26.2% | $428.9M-30.5% | $616.9M-16.6% | $739.9M+17.3% | $630.9M+51.8% | $415.6M+108.7% |
| Cash & Equivalents | $57.0M-37.4% | $91.1M-31.9% | $133.7M+4.0% | $128.6M-44.2% | $230.4M-33.9% | $348.4M+34.5% | $259.0M+23.5% | $209.7M+272.4% |
| Short-Term Investments | $0-100.0% | $997K-80.7% | $5.2M+3.6% | $5.0M+63.8% | $3.0M+7.5% | $2.8M+14.4% | $2.5M-66.4% | $7.3M+248.1% |
| Inventory | $72.8M+28.1% | $56.8M-33.1% | $84.9M-42.7% | $148.2M-24.4% | $196.0M+5.1% | $186.6M+45.3% | $128.4M+82.1% | $70.5M+83.6% |
| Accounts Receivable | $66.9M+6.3% | $63.0M+3.7% | $60.7M-38.6% | $98.9M+17.3% | $84.3M+84.5% | $45.7M+68.3% | $27.1M+216.7% | $8.6M+69.6% |
| Long-Term Investments | $220.0M-2.6% | $225.9M-5.3% | $238.5M-2.5% | $244.5M+0.4% | $243.6M+258.1% | $68.0M+16.6% | $58.3M+91.9% | $30.4M+132.0% |
| Goodwill | $9.6M0.0% | $9.6M0.0% | $9.6M0.0% | $9.6M0.0% | $9.6M0.0% | $9.6M+1024.5% | $852K-1.2% | $862K-5.4% |
| Total Liabilities | $350.3M+27.0% | $275.9M-2.4% | $282.8M-24.5% | $374.5M-24.3% | $494.6M+1.7% | $486.4M+26.5% | $384.6M+82.5% | $210.7M+10.6% |
| Current Liabilities | $286.8M+46.8% | $195.4M+26.0% | $155.1M-35.9% | $241.9M-28.4% | $337.7M-21.0% | $427.5M+19.9% | $356.5M+76.6% | $201.8M+49.7% |
| Non-Current Liabilities | $63.5M-21.2% | $80.5M-36.9% | $127.7M-3.7% | $132.5M-15.5% | $156.9M+166.8% | $58.8M+109.6% | $28.1M+215.2% | $8.9M-84.0% |
| Long-Term Debt | $59.5M-21.0% | $75.2M-37.3% | $120.0M+21.0% | $99.2M-13.0% | $114.1M+1140.4% | $9.2M | N/A | N/A |
| Total Equity | $214.5M-14.7% | $251.6M-28.3% | $350.9M-9.4% | $387.5M-15.4% | $458.3M+9.5% | $418.4M+16.5% | $359.2M+36.4% | $263.4M+659.0% |
| Retained Earnings | -$11.4M-140.0% | $28.6M-72.6% | $104.4M-23.7% | $136.7M-31.5% | $199.5M+14.8% | $173.7M+32.8% | $130.8M+164.5% | $49.5M+145.3% |
ZEPP Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
ZEPP Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Zepp Health Corporation ZEPP | FY2025 | $258.9M | -$40.1M | -15.5% | $54.6M | 26/100 |
| GoPro, Inc. GPRO | FY2025 | $651.5M | -$93.5M | -14.3% | $245.6M | 20/100 |
| Sonos, Inc. SONO | FY2025 | $1.4B | -$61.1M | -4.2% | $2.0B | 31/100 |
| Vuzix Corporation VUZI | FY2025 | $6.3M | -$32.3M | N/A | $216.1M | 48/100 |
| LG Display Co. Ltd. LPL | FY2009 | $17.2B | $954.5M | 5.5% | $2.9B | — |
| UTime Limited WTO | FY2025 | $34.6M | -$92.3M | N/A | $1.4M | 43/100 |
Where Zepp Health Corporation Ranks
Frequently Asked Questions
What is Zepp Health Corporation's annual revenue?
Zepp Health Corporation (ZEPP) reported $258.9M in total revenue for fiscal year 2025. This represents a 41.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Zepp Health Corporation's revenue growing?
Zepp Health Corporation (ZEPP) revenue grew by 41.8% year-over-year, from $182.6M to $258.9M in fiscal year 2025.
Is Zepp Health Corporation profitable?
No, Zepp Health Corporation (ZEPP) reported a net income of -$40.1M in fiscal year 2025, with a net profit margin of -15.5%.
What is Zepp Health Corporation's EBITDA?
Zepp Health Corporation (ZEPP) had EBITDA of -$24.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Zepp Health Corporation have?
As of fiscal year 2025, Zepp Health Corporation (ZEPP) had $57.0M in cash and equivalents against $59.5M in long-term debt.
What is Zepp Health Corporation's gross margin?
Zepp Health Corporation (ZEPP) had a gross margin of 38.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Zepp Health Corporation's operating margin?
Zepp Health Corporation (ZEPP) had an operating margin of -11.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Zepp Health Corporation's net profit margin?
Zepp Health Corporation (ZEPP) had a net profit margin of -15.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Zepp Health Corporation's return on equity (ROE)?
Zepp Health Corporation (ZEPP) has a return on equity of -18.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Zepp Health Corporation's free cash flow?
Zepp Health Corporation (ZEPP) recorded an outflow of $26.2M in free cash flow during fiscal year 2025. This represents a -1.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Zepp Health Corporation's operating cash flow?
Zepp Health Corporation (ZEPP) recorded an outflow of $25.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Zepp Health Corporation's total assets?
Zepp Health Corporation (ZEPP) had $564.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Zepp Health Corporation's capital expenditures?
Zepp Health Corporation (ZEPP) invested $516K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Zepp Health Corporation spend on research and development?
Zepp Health Corporation (ZEPP) invested $45.3M in research and development during fiscal year 2025.
What is Zepp Health Corporation's current ratio?
Zepp Health Corporation (ZEPP) had a current ratio of 1.02 as of fiscal year 2025, which is considered adequate.
What is Zepp Health Corporation's debt-to-equity ratio?
Zepp Health Corporation (ZEPP) had a debt-to-equity ratio of 0.28 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Zepp Health Corporation's return on assets (ROA)?
Zepp Health Corporation (ZEPP) had a return on assets of -7.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Zepp Health Corporation's P/E ratio?
Zepp Health Corporation (ZEPP) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $54.6M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Zepp Health Corporation's price-to-sales ratio?
Zepp Health Corporation (ZEPP) trades at 0.2x sales, its market capitalization divided by revenue of $258.9M revenue, FY2025. The market capitalization is $54.6M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Zepp Health Corporation's Altman Z-Score?
Zepp Health Corporation (ZEPP) has an Altman Z-Score of 0.37, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Zepp Health Corporation's Piotroski F-Score?
Zepp Health Corporation (ZEPP) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Zepp Health Corporation's earnings high quality?
Zepp Health Corporation (ZEPP) reported a net loss of $40.1M while operations used $25.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Zepp Health Corporation cover its interest payments?
Zepp Health Corporation (ZEPP) reported an operating loss of $29.2M against $5.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Zepp Health Corporation?
Zepp Health Corporation (ZEPP) scores 26 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.